1. What is the Chemxpert database?

Chemxpert database is a techno-commercial information platform developed and operated by Lifescience Intellipedia Pvt. Ltd. Our data provides valuable insights regarding sourcing, marketing, development, and regulatory functions for the entire Lifescience industry. The different industries covered by our data encompass APIs, FDFs, pharma intermediates, paints, dyes, polymers, biotechnology, biochemical, food additives, nutraceuticals, etc.

2. How can I subscribe to the Chemxpert database?

You can gain access to the Chemxpert database after subscribing to it by visiting this link: - https://chemxpert.com/pricing

3. How many countries' data is available on your portal?

The Chemxpert database covers more than 200 countries. We are working in the direction of expanding our data coverage in more countries.

4. What are the different sources you use for obtaining information?

The different sources we use for data collection are as follows: - • Primary researc • DMF, ANDA, & CEP list • Conferences, Exhibitions, & Tradeshow • Company annual reports • DMF, ANDA, & CEP list • Subject matter experts & KOL survey. Apart from these, our other valuable sources include application-wise manufacturers list, subscribed and non-subscribed databases, corporate partners, US FDA Orange book, publicly available sources, industry associates, national statistics, regulatory websites, etc. You can gain access to the Chemxpert database after subscribing to it by visiting this link: -https://chemxpert.com/sources

5. What is the expected time for account activation?

Your Chemxpert account will be activated instantly if the payment is made through our website. If you choose to use RTGS, NEFT, or IMPS systems for payment, your account will be activated within 24 hours.

16 Apr 2024
Admin
News Article

BC Platforms and NTT Group Soon to Inaugurate Debut of Japanese Precision Medicine Platform

BC Platforms and NTT Group Announce Inaugural Ceremony for Exclusive Collaboration and Debut of Japanese Precision Medicine Platform

Overview

BC Platforms (BCP) and NTT Life Science Corporation have teamed up in an exclusive partnership to advance data-driven medicine, particularly in Japan. The collaboration, which was officially inaugurated at a joint facility opening ceremony in Tokyo, aims to spearhead the Japan Precision Medicine PlatformTM (JPP), facilitating the secure and efficient use of clinical data across the nation.

Rights Post Partnership

This partnership, announced in October 2023, grants BCP and NTT exclusive rights within the Japanese market under the JPP umbrella.
Through a multiyear effort, the platform will integrate, curate, and harmonize healthcare data, fostering collaboration among researchers to accelerate the development of new therapies.

For Positive Impact on Patient Care

Laurent Samama, Chairman of the Board at BCP, expressed enthusiasm for the partnership, emphasizing its role in scaling up their capabilities and maximizing their value proposition.
The collaboration targets a positive impact on patient care through personalized medicine, utilizing real-world data to identify suitable candidates for clinical trials.

Strategic Goal of NTT

NTT's strategic goal of creating value through data-driven technology aligns with this partnership, as outlined in their medium-term management strategy.
Akiko Kudo of NTT emphasized the importance of quickly establishing a market presence alongside BCP, a globally recognized player in the medical field.

Words from CEO: NTT Life Science

Kouji Korekawa, President and CEO of NTT Life Science, highlighted their commitment to revolutionizing healthcare solutions, drawing upon their extensive experience in medical research. Leveraging their existing network and expertise, they aim to drive adoption of the JPP across Japan.

Aim of This Collaboration

• Nino da Silva, Managing Director APAC at BC Platforms, underscored the combined strength of NTT's infrastructure and BCP's technology in building a robust medical data ecosystem.
• The collaboration aims to provide unparalleled access to real-world data for global pharmaceutical companies and research organizations.

Let’s apply Data-Driven Pricing to Your APIs

Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.

Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.

Start using market intelligence today and allow yourself to be in control in the API market.

Check it out today and make more informed sourcing decisions! Learn More!